Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells


Notch1 is a potent regulator known to play an oncogenic role in many malignancies including T-cell acute lymphoblastic leukemia (T-ALL). Tumor hypoxia and increased hypoxia-inducible factor-1alpha (HIF-1alpha) activity can act as major stimuli for tumor aggressiveness and progression.

Although hypoxia-mediated activation of the Notch1 pathway plays an important role in tumor cell survival and invasiveness, the interaction between HIF-1alpha and Notch1 has not yet been identified in T-ALL. This study was designed to investigate whether hypoxia activates Notch1 signalling through HIF-1alpha stabilization and to determine the contribution of hypoxia and HIF-1alpha to proliferation, invasion and chemoresistance in T-ALL.

Methods: T-ALL cell lines (Jurkat, Sup-T1) transfected with HIF-1alpha or Notch1 small interference RNA (siRNA) were incubated in normoxic or hypoxic conditions.

Their potential for proliferation and invasion was measured by WST-8 and transwell assays. Flow cytometry was used to detect apoptosis and assess cell cycle regulation.

Expression and regulation of components of the HIF-1alpha and Notch1 pathways and of genes related to proliferation, invasion and apoptosis were assessed by quantitative real-time PCR or Western blot.

Results: Hypoxia potentiated Notch1 signalling via stabilization and activation of the transcription factor HIF-1alpha. Hypoxia/HIF-1alpha-activated Notch1 signalling altered expression of cell cycle regulatory proteins and accelerated cell proliferation.

Hypoxia-induced Notch1 activation increased the expression of matrix metalloproteinase-2 (MMP2) and MMP9, which increased invasiveness. Of greater clinical significance, knockdown of Notch1 prevented the protective effect of hypoxia/HIF-1alpha against dexamethasone-induced apoptosis.

This sensitization correlated with losing the effect of hypoxia/HIF-1alpha on Bcl-2 and Bcl-xL expression.

Conclusions: Notch1 signalling is required for hypoxia/HIF-1alpha-induced proliferation, invasion and chemoresistance in T-ALL. Pharmacological inhibitors of HIF-1alpha or Notch1 signalling may be attractive interventions for T-ALL treatment.

Author: Jie ZouPeng LiFei LuNa LiuJianjian DaiJingjing YeXun QuXiulian SunDaoxin MaJino ParkChunyan Ji
Credits/Source: Journal of Hematology &Oncology 2013, 6:3



Published on: 2013-01-05



News Provider: 7thSpace Interactive / EUPB Press Office

Copyright by the authors listed above - made available via BioMedCentral (Open Access). Please make sure to read our disclaimer prior to contacting 7thSpace Interactive. To contact our editors, visit our online helpdesk. If you wish submit your own press release, click here.

Social Bookmarking
RETWEET This! | Digg this! | Post to del.icio.us | Post to Furl | Add to Netscape | Add to Yahoo! | Rojo



Comments

There are no comments available. Be the first to write a comment.


You need to enable Javascript to post a comment.


Custom Search

Username
Password










© 2014 7thSpace Interactive
All Rights Reserved - About | Disclaimer | Helpdesk